In vitro effect of etomidate and thiopental on granulocyte migration

Insights

Long-term etomidate infusion may increase mortality. However, this study found etomidate does not impair granulocyte migration, suggesting other host defense factors may be involved.

Area of Science:

  • Anesthesiology
  • Immunology
  • Critical Care Medicine

Background:

  • Long-term etomidate infusion is associated with increased mortality.
  • Adrenal corticosteroid synthesis inhibition is a suspected cause.
  • Other host defense mechanisms require investigation.

Purpose of the Study:

  • To investigate the effect of etomidate on granulocyte migration in vitro.
  • To determine if etomidate impacts spontaneous or directed granulocyte movement.

Main Methods:

  • An under-agarose assay was employed to assess granulocyte migration.
  • Etomidate was tested at concentrations of 4-32 micrograms/ml.
  • Thiopental served as a comparative agent.

Main Results:

  • Etomidate did not affect spontaneous granulocyte migration.
  • Etomidate did not affect directed granulocyte migration.
  • Thiopental at 50 micrograms/ml did not inhibit migration (control observation).

Conclusions:

  • Impaired granulocyte migration is unlikely to be the cause of morbidity during long-term etomidate infusion.
  • The role of other host defense factors in etomidate-related mortality warrants further study.

Related Concept Videos